Ms Beatrijs Gielen

Beatrijs Gielen


Competition & Antitrust

Does competition law allow competing researchers to collaborate on COVID-19-related R&D?
European Union | 23 April 2020

New vaccines, quick and trustworthy diagnostic tests and effective medicines are key to tackling the COVID-19 pandemic. The development of these products depends on pharmaceutical companies, R&D companies, research institutes and universities. However, one question remains: what are the competition rules regarding COVID-19-related R&D?